Prevention of graft rejection by donor type II CD8+ T Cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation

Fetal Diagnosis and Therapy

Volumn 20, Issue 1, 2005, Pages 35-43

  Chen, Jeng Chang ^a,b   Chang, Ming Ling ^a,c   Lee, Hanmin ^a   Muench, Marcus O ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytotoxic T cells; Fetal transplantation; Immune tolerance; Peritoneal chimerism

Indexed keywords

CD8 ANTIGEN;

ACUTE GRAFT REJECTION; ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHIMERAPLASTY; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; IN UTERO STEM CELL TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE CULTURE; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FETUS; GRAFT REJECTION; MICE; MICE, INBRED STRAINS; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 11444266159     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081367     Document Type: Article

References (35)

1. Flake AW, Zanjani ED: In utero hematopoietic stem cell transplantation. A status report. JAMA 1997;278:932-937.
2. Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, Evans MI, Johnson MP, Abella EM, Harrison DD, Zanjani ED: Treatment of Xlinked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806-1810.
3. Muench MO, Bárcena A: Stem cell transplantation in the fetus. Cancer Control 2004;11:105-118.
4. Zanjani ED, Pallavicini MG, Ascensao JL, Flake AW, Langlois RG, Reitsma M, MacKintosh FR, Stutes D, Harrison MR, Tavassoli M: Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992;89:1178-1188.
5. Carrier E, Lee TH, Busch MP, Cowan MJ: Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 1995;86:4681-4690.
6. Hajdu K, Tanigawara S, McLean LK, Cowan MJ, Golbus MS: In utero allogeneic hematopoietic stem cell transplantation to induce tolerance. Fetal Diagn Ther 1996;11:241-248.
7. Milner R, Shaaban A, Kim HB, Fichter C, Flake AW: Postnatal booster injections increase engraftment after in utero stem cell transplantation. J Surg Res 1999;83:44-47.
8. Kim HB, Shaaban AF, Yang EY, Liechty KW, Flake AW: Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 1998;77:1-5.
9. Carrier E, Lee TH, Busch MP, Cowan MJ: Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice. Transplantation 1997;64:627-633.
10. Flake AW, Zanjani ED: In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers. Blood 1999;94:2179-2191.
11. + cells for chronic granulomatous disease. Bone Marrow Transplant 2001;27:355-364.
12. Martin PJ: Determinants of engraftment after allogeneic marrow transplantation. Blood 1992;79:1647-1650.
13. Martin PJ, Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, Sanders J, Sullivan KM, Witherspoon RP, Deeg HJ, et al: Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 1988;3:445-456.
14. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, et al: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985;66:664-672.
15. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ: Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-vs.-host disease. Blood 1986;68:770-773.
16. Korngold R, Sprent J: Surface markers of T cells causing lethal graft-vs.-host disease to class I vs. class II H-2 differences. J Immunol 1985;135:3004-3010.
17. Shields LE, Andrews RG: In utero stem cell transplantation in non-human primates: The role of T-cells number (abstract). Am J Obstet Gynecol 2001;184:S2.
18. Crombleholme TM, Harrison MR, Zanjani ED: In utero transplantation of hematopoietic stem cells in sheep: The role of T cells in engraftment and graft-versus-host disease. J Pediatr Surg 1990;25:885-892.
19. Bhattacharyya S, Chawla A, Smith K, Zhou Y, Talib S, Wardwell B, Cowan MJ: Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of s-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice. J Immunol 2002;169:6133-6140.
20. Martin PJ: Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans. J Exp Med 1993;178:703-712.
21. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation 1995;60:355-361.
22. Martin PJ, Rowley SD, Anasetti C, Chauncey TR, Gooley T, Petersdorf EW, van Burik JA, Flowers ME, Storb R, Appelbaum FR, Hansen JA: A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood 1999;94:2192-2199.
23. Martin PJ, Akatsuka Y, Hahne M, Sale G: Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 1998;92:2177-2181.
24. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 1999;11:579-590.
25. + T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271-279.
26. Croft M, Carter L, Swain SL, Dutton RW: Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994;180:1715-1728.
27. + T cells of Tc2 phenotype mediate a GVL effect and prevent marrow rejection. Vox Sang 1998;74:331-340.
28. + T cells of Tc2 phenotype potently inhibit marrow graft rejection. Blood 1998;91:4045-4050.
29. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J Immunol 1996;157:4811-4821.
30. Fowler DH, Gress RE: Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: Considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma 2000;38:221-234.
31. Chen JC, Chang ML, Muench MO: A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J Immunol Meth 2003;279:123-133.
32. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SEW, Dubois CM, Kopp WC, Longo DL, Keller JR: Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991;147:22-28.
33. Defresne MP, Humblet C, Deman J, et al: Ontogeny of T-cell surface molecules and receptors in the thymus. Prog Histochem Cytochem 1992;26:194-200.
34. Donahue J, Gilpin E, Lee TH, Busch MP, Croft M, Carrier E: Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation 2001;71:359-368.
35. Hiruma K, Nakamura H, Henkart PA, Gress RE: Clonal deletion of postthymic T cells: Veto cells kill precursor cytotoxic T lymphocytes. J Exp Med 1992;175:863-868.